CoChat

HIV-1 Reverse Transcriptase Structure with RNase H Inhibitor Dihydroxy Benzoyl Naphthyl Hydrazone Bound at a Novel Site

Open access
Himmel, Daniel M., Sarafianos, Stefan G., Dharmasena, Sanjeewa, Hossain, Mohammed M., McCoy-Simandle, Kessler, Ilina, Tatiana, Clark, Arthur D., Knight, Jennifer L., Julias, John G., Clark, Patrick K., Krogh-Jespersen, Karsten, Levy, Ronald M., Hughes, Stephen H., Parniak, Michael A., Arnold, Eddy · 2006 · ACS Chemical Biology
Cited by 140

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

The rapid emergence of drug-resistant variants of human immunodeficiency virus, type 1 (HIV-1), has limited the efficacy of anti-acquired immune deficiency syndrome (AIDS) treatments, and new lead compounds that target novel binding sites are needed. We have determined the 3.15 A resolution crystal structure of HIV-1 reverse transcriptase (RT) complexed with dihydroxy benzoyl naphthyl hydrazone (DHBNH), an HIV-1 RT RNase H (RNH) inhibitor (RNHI). DHBNH is effective against a variety of drug-resistant HIV-1 RT mutants. While DHBNH has little effect on most aspects of RT-catalyzed DNA synthesis, at relatively high concentrations it does inhibit the initiation of RNA-primed DNA synthesis. Although primarily an RNHI, DHBNH binds >50 A away from the RNH active site, at a novel site near both the polymerase active site and the non-nucleoside RT inhibitor (NNRTI) binding pocket. When DHBNH binds, both Tyr181 and Tyr188 remain in the conformations seen in unliganded HIV-1 RT. DHBNH interacts with conserved residues (Asp186, Trp229) and has substantial interactions with the backbones of several less well-conserved residues. On the basis of this structure, we designed substituted DHBNH derivatives that interact with the NNRTI-binding pocket. These compounds inhibit both the polymerase and RNH activities of RT.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1021/cb600303y

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 48

  1. Coffin, 1997, Retroviruses
  2. Tisdale, 1991, Mutations within the RNase H domain of HIV-1 RT abolish virus infectivity, J. Gen. Virol., 72, 59, 10.1099/0022-1317-72-1-59 · DOI · Paper page
  3. Huang, 1998, Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: Implications for drug resistance, Science, 282, 1669, 10.1126/science.282.5394.1669 · DOI · Paper page
  4. Sarafianos, 2001, Crystal structure of HIV-1 reverse transcriptase in complex with a polypurine tract RNA:DNA, EMBO J., 20, 1449, 10.1093/emboj/20.6.1449 · DOI · Paper page
  5. Rittinger, 1995, Human immunodeficiency virus reverse transcriptase substrate-induced conformational changes and the mechanism of inhibition by nonnucleoside inhibitors, Proc. Natl. Acad. Sci. U.S.A., 92, 8046, 10.1073/pnas.92.17.8046 · DOI · Paper page
  6. Spence, 1995, Mechanism of inhibition of HIV-1 reverse transcriptase by nonnucleoside inhibitors, Science, 267, 988, 10.1126/science.7532321 · DOI · Paper page
  7. Rodgers, 1995, The structure of unliganded reverse transcriptase from the human immunodeficiency virus type 1, Proc. Natl. Acad. Sci. U.S.A., 92, 1222, 10.1073/pnas.92.4.1222 · DOI · Paper page
  8. Hsiou, 1996, Structure of unliganded HIV-1 reverse transcriptase at 2.7 Å resolution: Implications of conformational changes for polymerization and inhibition mechanisms, Structure, 4, 853, 10.1016/S0969-2126(96)00091-3 · DOI · Paper page
  9. Tantillo, 1994, Locations of anti-AIDS drug binding sites and resistance mutations in the three-dimensional structure of HIV-1 reverse transcriptase: implications for mechanisms of drug inhibition and resistance, J. Mol. Biol., 243, 369, 10.1006/jmbi.1994.1665 · DOI · Paper page
  10. Das, 1996, Crystal structures of 8-Cl and 9-Cl TIBO complexed with wild-type HIV-1 RT and 8-Cl TIBO complexed with the Tyr181Cys HIV-1 RT drug-resistant mutant, J. Mol. Biol., 264, 1085, 10.1006/jmbi.1996.0698 · DOI · Paper page
  11. Esnouf, 1995, Mechanism of inhibition of HIV-1 reverse transcriptase by non-nucleoside inhibitors, Nat. Struct. Biol., 2, 303, 10.1038/nsb0495-303 · DOI · Paper page
  12. Ding, 1997, Structural studies of HIV-1 reverse transcriptase and implications for drug design, 41
  13. Ding, 1998, Structure and functional implications of the polymerase active site region in a complex of HIV-1 RT with a double-stranded DNA template–primer and an antibody Fab fragment at 2.8 Å resolution, J. Mol. Biol., 284, 1095, 10.1006/jmbi.1998.2208 · DOI · Paper page
  14. Palaniappan, 1995, Nevirapine alters the cleavage specificity of ribonuclease H of human immunodeficiency virus 1 reverse transcriptase, J. Biol. Chem., 270, 4861, 10.1074/jbc.270.9.4861 · DOI · Paper page
  15. Shaw-Reid, 2005, Dissecting the effects of DNA polymerase and ribonuclease H inhibitor combinations on HIV-1 reverse-transcriptase activities, Biochemistry, 44, 1595, 10.1021/bi0486740 · DOI · Paper page
  16. Gopalakrishnan, 1994, Effect of a thiobenzimidazolone derivative on DNA strand transfer catalyzed by HIV-1 reverse transcriptase, J. Biol. Chem., 269, 4110, 10.1016/S0021-9258(17)41750-9 · DOI
  17. Sarafianos, 2004, Taking aim at a moving target: designing drugs to inhibit drug-resistant HIV-1 reverse transcriptases, Curr. Opin. Struct. Biol., 14, 716, 10.1016/j.sbi.2004.10.013 · DOI
  18. Borkow, 1997, Inhibition of the ribonuclease H and DNA polymerase activities of HIV-1 reverse transcriptase by N-(4-tert-butylbenzoyl)-2-hydroxy-1-naphthaldehyde hydrazone, Biochemistry, 36, 3179, 10.1021/bi9624696 · DOI · Paper page
  19. Sluis-Cremer, 2002, Destabilization of the HIV-1 reverse transcriptase dimer upon interaction with N-acyl hydrazone inhibitors, Mol. Pharmacol., 62, 398, 10.1124/mol.62.2.398 · DOI
  20. Shaw-Reid, 2003, Inhibition of HIV-1 ribonuclease H by a novel diketo acid, 4-[5-(benzoylamino)thien-2-yl]-2,4-dioxobutanoic acid, J. Biol. Chem., 278, 2777, 10.1074/jbc.C200621200 · DOI · Paper page
  21. Ding, 1995, Structure of HIV-1 RT/TIBO R 86183 complex reveals similarity in the binding of diverse non-nucleoside inhibitors, Nat. Struct. Biol., 2, 407, 10.1038/nsb0595-407 · DOI · Paper page
  22. Ren, 1995, High resolution structures of HIV-1 RT from four RT-inhibitor complexes, Nat. Struct. Biol., 2, 293, 10.1038/nsb0495-293 · DOI · Paper page
  23. Allen, 2002, The Cambridge Structural Database: A quarter of a million crystal structures and rising, Acta Crystallogr. B, 58, 380, 10.1107/S0108768102003890 · DOI · Paper page
  24. Pata, 2004, Structure of HIV-1 reverse transcriptase bound to an inhibitor active against mutant reverse transcriptases resistant to other nonnucleoside inhibitors, Proc. Natl. Acad. Sci. U.S.A., 101, 10548, 10.1073/pnas.0404151101 · DOI
  25. Das, 2004, Roles of conformational and positional adaptability in structure-based design of TMC125-R165335 (etravirine) and related non-nucleoside reverse transcriptase inhibitors that are highly potent and effective against wild-type and drug-resistant HIV-1 variants, J. Med. Chem., 47, 2550, 10.1021/jm030558s · DOI · Paper page
  26. Das, 2005, Crystallography and the design of anti-AIDS drugs: conformational flexibility and positional adaptability are important in the design of non-nucleoside HIV-1 reverse transcriptase inhibitors, Prog. Biophys. Mol. Biol., 88, 209, 10.1016/j.pbiomolbio.2004.07.001 · DOI · Paper page
  27. Guillemont, 2005, Synthesis of novel diarylpyrimidine analogues and their antiviral activity against human immunodeficiency virus type 1, J. Med. Chem., 48, 2072, 10.1021/jm040838n · DOI
  28. Janssen, 2005, In search of a novel anti-HIV drug: multidisciplinary coordination in the discovery of 4-[[4-[[4-[(1E)-2-cyanoetenyl]-2-6-dimethylphenyl]amino]-2-pyrimidinyl]amino]-benzonitrile (R278474-rilpivirine), J. Med. Chem., 48, 1901, 10.1021/jm040840e · DOI · Paper page
  29. Ghosh, 1996, Alterations to the primer grip of P66 HIV-1 reverse transcriptase and their consequences for template–primer utilization, Biochemistry, 35, 8553, 10.1021/bi952773j · DOI · Paper page
  30. Ghosh, 1997, Mutating a conserved motif of the HIV-1 reverse transcriptase palm subdomain alters primer utilization, Biochemistry, 36, 5758, 10.1021/bi963045e · DOI
  31. Palaniappan, 1997, Mutations within the primer grip region of HIV-1 reverse transcriptase result in loss of RNase H function, J. Biol. Chem., 272, 11157, 10.1074/jbc.272.17.11157 · DOI · Paper page
  32. Powell, 1997, Alanine-scanning mutations in the "primer grip" of P66 HIV-1 reverse transcriptase result in selective loss of RNA priming activity, J. Biol. Chem., 272, 13262, 10.1074/jbc.272.20.13262 · DOI · Paper page
  33. Gao, 1998, Effects of mutations in the polymerase domain on the polymerase, RNase H and strand transfer activities of human immunodeficiency virus type 1 reverse transcriptase, J. Mol. Biol., 277, 559, 10.1006/jmbi.1998.1624 · DOI
  34. Powell, 1999, Residues in the alphaH and alphaI helices of the HIV-1 reverse transcriptase thumb subdomain required for the specificity of RNase H-catalyzed removal of the polypurine tract primer, J. Biol. Chem., 274, 19885, 10.1074/jbc.274.28.19885 · DOI · Paper page
  35. Edward, 1988, Synthesis of new acylhydrazones as iron-chelating compounds, J. Chem. Eng. Data, 33, 538, 10.1021/je00054a044 · DOI · Paper page
  36. Clark, 1995, Crystallization of human immunodeficiency virus type 1 reverse transcriptase with and without nucleic acid substrates, inhibitors and an antibody Fab fragment, Methods Enzymol., 262, 171, 10.1016/0076-6879(95)62017-6 · DOI
  37. Carroll, 2000, Only a small fraction of purified hepatitis C RNA-dependent RNA polymerase is catalytically competent: Implications for viral replication and in vitro assays, Biochemistry, 39, 8243, 10.1021/bi991992s · doi:10.1021/bi991992s
  38. Parniak, 2003, A fluorescence-based high-throughput screening assay for inhibitors of human immunodeficiency virus-1 reverse transcriptase-associated ribonuclease H activity, Anal. Biochem., 322, 33, 10.1016/j.ab.2003.06.001 · DOI
  39. Julias, 2001, Replication of phenotypically mixed human immunodeficiency virus type 1 virions containing catalytically active and catalytically inactive reverse transcriptase, J. Virol., 75, 6537, 10.1128/JVI.75.14.6537-6546.2001 · DOI
  40. Otwinowski, 2001, DENZO and SCALEPACK, 226
  41. Frisch, 1998, Gaussian 98
  42. Becke, 1993, Density-functional thermochemistry. III. The role of exact exchange, J. Chem. Phys., 98, 5648, 10.1063/1.464913 · DOI · Paper page
  43. Lee, 1988, Development of the Colle–Salvetti correlation-energy formula into a functional of the electron density, Phys. Rev. B: Condens. Matter, 37, 785, 10.1103/PhysRevB.37.785 · DOI · Paper page
  44. Jacobson, 2004, A hierarchical approach to all-atom loop prediction, Proteins: Struct., Funct., Bioinf., 55, 351, 10.1002/prot.10613 · DOI · Paper page
  45. Gallicchio, 2004, AGBNP: an analytic implicit solvent model suitable for molecular dynamics simulations and high-resolution modeling, J. Comput. Chem., 25, 479, 10.1002/jcc.10400 · DOI · Paper page
  46. Navaza, 1994, AMoRe: an automated package for molecular replacement, Acta Crystallogr. A, 50, 157, 10.1107/S0108767393007597 · DOI · Paper page
  47. Jones, 1991, Improved experimental procedures for building protein models in electron-density maps and the location of errors in these models, Acta Crystallogr. A, 47, 110, 10.1107/S0108767390010224 · DOI · Paper page
  48. Brünger, 1998, Crystallography and NMR system: a new software suite for macromolecular structure determination, Acta Crystallogr. D, 54, 905, 10.1107/S0907444998003254 · DOI · Paper page

Cited by

See all 140

Metadata

Authors
Himmel, D. M., Sarafianos, S. G., Dharmasena, S., Hossain, M. M., McCoy-Simandle, K., Ilina, T., Clark, A. D., Knight, J. L., Julias, J. G., Clark, P. K., Krogh-Jespersen, K., Levy, R. M., Hughes, S. H., Parniak, M. A., & Arnold, E.
Venue
ACS Chemical Biology
Published
2006-11-28
Volume
1
Issue
11
Pages
702-712
ISSN
  • 1554-8929 (ISSN-L)
  • 1554-8937
OpenAlex
W2030926399
Cited by
140
References
3
FWCI
3.63
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: HIV-1 Reverse Transcriptase Structure with RNase H Inhibitor Dihydroxy Benzoyl Naphthyl Hydrazone Bound at a Novel Site. https://app.cochat.ai/papers/10.1021/cb600303y
The paper
Himmel, D. M., Sarafianos, S. G., Dharmasena, S., Hossain, M. M., McCoy-Simandle, K., Ilina, T., Clark, A. D., Knight, J. L., Julias, J. G., Clark, P. K., Krogh-Jespersen, K., Levy, R. M., Hughes, S. H., Parniak, M. A., & Arnold, E. (2006). HIV-1 Reverse Transcriptase Structure with RNase H Inhibitor Dihydroxy Benzoyl Naphthyl Hydrazone Bound at a Novel Site. ACS Chemical Biology. https://doi.org/10.1021/cb600303y

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.